


		Home What's New Dr. Law's Response to His Critics Myoblast vs. Stem Cells Videos Patents & Licenses FAQ Contact Us
				Established in 1997, Cell Transplants International, LLC (CTI) is dedicated to finding treatments for muscular dystrophy, heart, type II diabetes, and other hereditary degenerative diseases. Our current work focuses on heart angiomyogenesis using myoblasts. CTI's pioneering work has developed over the past 33 years and is the first research into human cell/gene therapy. It is the only human genome therapy in existence. Extensive experience in large-scale production of pure myoblasts and intellectual property portfolio encompassing the production and use of myoblasts give CTI a unique advantage over its competitors. Be sure to visit the What's New section to read about our latest development in heart treatment. Click here to visit the Human Genome Therapy Research website.

Copyright © 2003-4 Cell Transplants International, LLC. All Rights Reserved. IX

Buy Viagra